Introduction: Erectile dysfunction (ED) is a common complication of diabetes mellitus (DM) that is associated with poor quality of life and can be present in type 2 diabetics at the time of diagnosis. There are common risk factors associated with erectile dysfunction in type 2 diabetic subjects. Some of these are potentially treatable or reversible. The risk factors evaluated by this study included glycaemic control, duration of diabetes, obesity, peripheral artery disease (PAD), hypertension and antihypertensive medications use. Materials and Methods: This study was a cross sectional one carried out over a period of six months (June-November, 2016) at the diabetes clinic of the Nnamdi Azikiwe University Teaching Hospital, Nnewi and involved 124 subjects with type 2 diabetes mellitus. A convenience sampling method was used. A detailed physical examination, blood pressure and anthropometric measurements and vascular assessment with a hand-held doppler ultrasound were carried out. Data was collected using a study proforma. Erectile dysfunction was diagnosed with the International Index of Erectile Function questionnaire while anxiety and depression were diagnosed with the Hospital Anxiety and Depression questionnaires. Subjects that had anxiety/depression or hypogonadism were excluded from the study. Results: A total of 124 subjects were studied, 48.4% of whom had erectile dysfunction. Glycaemic control was significantly associated with ED among the subjects (OR = 0.198, 95% CI = 0.

IntroductionThe WHO has proposed the concept of mobile health (mHealth) to support healthcare systems delivery worldwide. mHealth basically involves the use of Information and Communication Technology for healthcare provision or delivery services. Africa has seen a remarkable increase in mobile phone availability and usage in the last decade. The incidence and prevalence of diabetes mellitus (DM) in Africa have also been on the increase in the last decade, in sharp contrast to an ailing healthcare system. We aim to review the extent of implementation of mHealth in the management of DM in Africa, and estimate its impact in helping patients achieve desired glycaemic target, sustain control and prevent complications in the past decade.Methods and analysisStudies assessing the utilisation of mhealth in the management of patients with DM in Africa will be considered based on the PICO method: Population, Intervention, Comparator, and Outcomes. Medline, PubMed, SCOPUS and the Pan African Clinical Trials Registry, among others will be searched. Two authors independent of each other shall screen titles and abstracts retrieved using the search strategy, retrieve the full text articles and assess them for eligibility and extract data. A third reviewing author will be brought in to resolve any disagreement between the two authors by discussion. The ‘Cochrane Collaboration Risk of Bias Tool’ will be used to assess the quality of included studies. A narrative synthesis of extracted data and, where the characteristics of the eligible studies permit, a meta-analysis (which will be reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines) will be done.Ethics and disseminationNo ethical approval will be required since only published data will be used. Dissemination of results will be through peer reviewed publication and conference presentation.PROSPERO registration numberCRD42021218674.

Background and Objective: Cardiovascular diseases (CVDs) are leading causes of non-communicable diseases and are increasingly becoming the major causes of morbidity and mortality in Nigeria. Published literature on the changing patterns and outcome of CVD admissions in the southeast region of Nigeria is scanty. This study, therefore, set out to bridge this gap in knowledge. Subjects and Methods: This was a 10-year retrospective descriptive study in which data about patients admitted on account of the CVDs to the medical wards of Abia State University Teaching Hospital (ABSUTH), Aba from May 1, 2007 to April 30, 2017 were extracted from the Admission/Discharge registers in the medical wards. Relevant data obtained were analyzed using Statistical Package for Social Sciences (SPSS) version 23.0 software. Results: A total of 2044 patients were admitted because of CVDs, made up of 927 (45.4%) males and 1117 (54.6%) females. Cerebrovascular disease (stroke), heart failure (HF) and uncontrolled systemic hypertension (SHTN) were the major cardiovascular indications for hospitalization at 44.08%, 38.85% and 15.31% respectively. With an overall CVD mortality of 24.9% of the medical admissions, the commonest cause of CVD deaths was stroke. Majority of the CVD deaths (70.9%) occurred within the first 7 days of hospitalization Conclusion: Contribution of cardiovascular diseases to medical admissions is considerable in Aba, Southeast Nigeria. In-patient mortality of the CVDs is high especially from stroke. It is recommended that every effort should be made to control the modifiable risk factors of CVDs while early detection and treatment of CVDs be effected. Keywords: Aba, cardiovascular diseases, medical wards, non-communicable diseases, Southeast, Nigeria